Literature DB >> 23328025

[Cross-over studies].

Tobias N Bonten1, Bob Siegerink, Johanna G van der Bom.   

Abstract

Randomized, parallel group clinical trials often require large groups of patients; this is expensive and takes time. A randomized cross-over trial can be an efficient and more affordable alternative. A cross-over design can be used to study chronic disorders in which treatments have temporary effects. Participants receive all treatments in consecutive periods and outcomes are measured after every period. In general, only a quarter of the total group size is needed for cross-over studies compared with parallel group studies. Results can be affected by period-effects and carry-over-effects, which can be prevented through randomization and a wash-out period of sufficient length. The dropping-out of participants has more negative consequences for cross-over studies than for parallel group studies.

Entities:  

Mesh:

Year:  2013        PMID: 23328025

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  7 in total

1.  Quality of life and paracetamol in advanced dementia (Q-PID): protocol of a randomised double-blind placebo-controlled crossover trial.

Authors:  Paulien H van Dam; Wilco P Achterberg; Jacobijn Gussekloo; Bettina S Husebo; Monique A A Caljouw
Journal:  BMC Geriatr       Date:  2018-11-14       Impact factor: 3.921

Review 2.  The crossover design for studies of infertility employing in-vitro fertilization: A methodological survey.

Authors:  Dalton R Budhram; Daniel Shi; Sarah D McDonald; Stephen D Walter
Journal:  Contemp Clin Trials Commun       Date:  2019-08-21

3.  Does paracetamol improve quality of life, discomfort, pain and neuropsychiatric symptoms in persons with advanced dementia living in long-term care facilities? A randomised double-blind placebo-controlled crossover (Q-PID) trial.

Authors:  Paulien H van Dam; Wilco P Achterberg; Bettina S Husebo; Monique A A Caljouw
Journal:  BMC Med       Date:  2020-12-21       Impact factor: 8.775

4.  Effect of various dialysis modalities on intradialytic hemodynamics, tissue injury and patient discomfort in chronic dialysis patients: design of a randomized cross-over study (HOLLANT).

Authors:  Paul A Rootjes; Menso J Nubé; Camiel L M de Roij van Zuijdewijn; Gertrude Wijngaarden; Muriel P C Grooteman
Journal:  BMC Nephrol       Date:  2021-04-15       Impact factor: 2.388

5.  High-Volume Hemodiafiltration and Cool Hemodialysis Have a Beneficial Effect on Intradialytic Hemodynamics: A Randomized Cross-Over Trial of Four Intermittent Dialysis Strategies.

Authors:  Paul A Rootjes; Sabrine Chaara; Camiel L M de Roij van Zuijdewijn; Menso J Nubé; Gertrude Wijngaarden; Muriel P C Grooteman
Journal:  Kidney Int Rep       Date:  2022-07-14

6.  Evaluating a Speech-Specific and a Computerized Step-Training-Specific Rhythmic Intervention in Parkinson's Disease: A Cross-Over, Multi-Arms Parallel Study.

Authors:  Anne Dorothée Rösch; Ethan Taub; Ute Gschwandtner; Peter Fuhr
Journal:  Front Rehabil Sci       Date:  2022-01-14

7.  Rivastigmine for ECT-induced cognitive adverse effects in late life depression (RECALL study): A multicenter, randomized, double blind, placebo-controlled, cross-over trial in patients with depression aged 55 years or older: Rationale, objectives and methods.

Authors:  Marieke J Henstra; Thomas C Feenstra; Rob M Kok; Harm-Pieter Spaans; Eric van Exel; Annemiek Dols; Mardien Oudega; Anton C M Vergouwen; Adriano van der Loo; Pierre M Bet; Stephan A Loer; Merijn Eikelenboom; Pascal Sienaert; Simon Lambrichts; Filip Bouckaert; Judith E Bosmans; Nathalie van der Velde; Aartjan T F Beekman; Max L Stek; Didi Rhebergen
Journal:  Front Psychiatry       Date:  2022-07-15       Impact factor: 5.435

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.